LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LeonaBio, Inc. reported a Form 4 showing a grant of stock options covering 28,000 shares of common stock to a board designee associated with Perceptive Advisors. The options have an exercise price of $9.54 per share and expire on April 8, 2036, vesting monthly over 24 months while the optionee continues as a Service Provider.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
PERCEPTIVE ADVISORS LLC, EDELMAN JOSEPH, PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Role
Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,000 shares (Indirect, See footnote)
Footnotes (1)
- The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates. Joseph Edelman ("Mr. Edelman") is the managing member of Perceptive Advisors LLC (the "Advisor"). The Advisor serves as the investment manager of Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). The Advisor may be deemed to have an indirect pecuniary interest in the securities reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Edelman's board service through a partial management fee offset. Each of the Master Fund and the Advisor disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that either the Master Fund or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Key Figures
Option Shares Granted: 28,000 shares
Exercise Price: $9.54 per share
Expiration Date: April 8, 2036
+2 more
5 metrics
Option Shares Granted
28,000 shares
Stock Option (Right to Buy) grant reported as of 2026-04-09
Exercise Price
$9.54 per share
Conversion or exercise price of the stock option grant
Expiration Date
April 8, 2036
Expiration of the stock options covering 28,000 underlying common shares
Vesting Term
24 months
Options vest monthly over 24 months, subject to continued Service Provider status
Shares Following Transaction
28,000 options
Total derivative securities held indirectly after the grant transaction
Key Terms
Stock Option (Right to Buy), 2026 Equity Incentive Plan, Service Provider, indirect pecuniary interest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
2026 Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan"
Service Provider financial
"subject to the optionee continuing to be a Service Provider"
indirect pecuniary interest financial
"may be deemed to have an indirect pecuniary interest in the securities"
beneficial ownership financial
"disclaim, for purposes of Section 16, beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did LeonaBio (LONA) report in this Form 4?
LeonaBio reported a grant of stock options for 28,000 shares of common stock to a board designee linked to Perceptive Advisors, with the award reported as an acquisition of a derivative security.
What is the exercise price of the new LeonaBio (LONA) stock options?
The granted stock options have an exercise price of $9.54 per share. This is the price at which the option holder may purchase LeonaBio common stock once the options vest and are exercised.
How do the LeonaBio (LONA) options granted in this filing vest?
The options covering 28,000 shares vest monthly over 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider under the 2026 Equity Incentive Plan.
When do the LeonaBio (LONA) stock options reported in this Form 4 expire?
The stock options reported expire on April 8, 2036. After that date, any unexercised portion of the 28,000-share option grant will no longer be exercisable by the holder.
Who is associated with the LeonaBio (LONA) option grant reported for Perceptive entities?
The filing states that Joseph Edelman is managing member of Perceptive Advisors, which manages Perceptive Life Sciences Master Fund Ltd., and may have an indirect pecuniary interest through a management fee offset tied to his board compensation.
Do Perceptive entities claim full beneficial ownership of the LeonaBio (LONA) options?
Perceptive Life Sciences Master Fund Ltd. and Perceptive Advisors disclaim beneficial ownership of the reported securities for Section 16 purposes, except to the extent of their indirect pecuniary interest, according to the footnote.